arrow
A

Anna Patten

Eisai Co Ltd
H指数:27
被引数:2,932

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term efficacy and safety of perampanel in patients aged 60 years and older with focal seizures: Post hoc analysis of phase III open-label extension studies stratified by enzyme-inducing anti-seizure medication use

60岁及以上局灶性癫痫患者中帕瑞斯潘的长期有效性与安全性:一项根据酶诱导型抗癫痫药物使用情况进行分层分析的三期开放标签扩展研究的事后分析

2025-12-010
OAAI
Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of phase III double-blind and open-label extension studies

中国局灶性癫痫发作或全身性强直-阵挛发作患者辅助perampanel的疗效、安全性和耐受性: III期双盲和开放标签扩展研究的事后分析

2020-09-0813
OAAI
Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures

开放性研究,以调查辅助perampanel在控制不足的局灶性癫痫发作或全身性强直阵挛发作的儿科患者 (4至 <12岁) 中的安全性和有效性

2020-01-0751
OAAI